Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
A Study of Venetoclax in Combination With Obinutuzumab in Participants With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01685892. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00419250. IPD Sharing: Not stated. Countries: 7. Publications: 1.
A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
ClinicalTrials.gov study NCT05023980. IPD Sharing: NO. Countries: 20. Publications: 0.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
ClinicalTrials.gov study NCT01081015. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Trial of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) in Older Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01681563. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00004245. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00391066. IPD Sharing: Not stated. Countries: 23. Publications: 4.
A Study of AZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT03328273. IPD Sharing: YES. Countries: 2. Publications: 1.
A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT05057494. IPD Sharing: YES. Countries: 7. Publications: 1.
A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia)
ClinicalTrials.gov study NCT04198415. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With
ClinicalTrials.gov study NCT01290549. IPD Sharing: Not stated. Countries: 4. Publications: 3.
Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00275015. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02316197. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Study to Investigate the Use of Acalabrutinib in the Treatment of Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT04178798. IPD Sharing: NO. Countries: 1. Publications: 55.
Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.
ClinicalTrials.gov study NCT00466895. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT01682616. IPD Sharing: NO. Countries: 2. Publications: 3.
Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT02518555. IPD Sharing: NO. Countries: 1. Publications: 1.
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT04704323. IPD Sharing: NO. Countries: 2. Publications: 1.
Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia
ClinicalTrials.gov study NCT02153580. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT04852822. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.